BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren T, Wang H, Wu R, Niu J. Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China. Gastroenterol Res Pract. 2017;2017:7089702. [PMID: 28831282 DOI: 10.1155/2017/7089702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Ding R, Zheng J, Huang D, Wang Y, Li X, Zhou X, Yan L, Lu W, Yang Z, Zhang Z. INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B. Int J Med Sci 2021;18:1159-66. [PMID: 33526976 DOI: 10.7150/ijms.51799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Palle SK, Naik KB, McCracken CE, Kolachala VL, Romero R, Gupta NA. Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver Int 2019;39:976-84. [PMID: 30802337 DOI: 10.1111/liv.14081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Lu W, Zhang YP, Zhu HG, Zhang T, Zhang L, Gao N, Chang DY, Yin J, Zhou XY, Li MY, Li YT, Li ZZ, He Q, Geng Y. Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci. 2019;76:137-142. [PMID: 31062646 DOI: 10.1080/09674845.2019.1615717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Alsebaey A, Elmazaly MA, Abougabal HM. Prediction of esophageal varices in patients with HCV-related cirrhosis using albumin-bilirubin, platelets-albumin-bilirubin score, albumin-bilirubin-platelets grade, and GAR. Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-00027-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yang Z, Ma X, Zhou X, Huang D, Wang Y, Li X, Lu W, Zhang Z, Ding R. Predictive performance of eLIFT for liver inflammation and fibrosis in chronic liver diseases. Int J Med Sci 2021;18:3599-608. [PMID: 34522187 DOI: 10.7150/ijms.62386] [Reference Citation Analysis]
6 Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 2019; 7(15): 2022-2037 [PMID: 31423434 DOI: 10.12998/wjcc.v7.i15.2022] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
7 Wu J, Mao W. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases. Dis Markers 2020;2020:2471252. [PMID: 32774512 DOI: 10.1155/2020/2471252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ouyang GX, Zhang YM, Zhu SL, Wang P, Ren Y, Li JH, Liu YK, Chen J, Xiang BD, Li LQ, Liu JY, Zhang ZM. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep 2018;8:13074. [PMID: 30166568 DOI: 10.1038/s41598-018-31351-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alsebaey A, Badr R, Abdelsameea E, Amer MO, Eljaky MA, El-azab G, Salama M. King’s Fibrosis, Fibrosis Index, GPR, and ALBI Score Are Useful Models for Liver Fibrosis in Chronic Hepatitis B Patients Pre- and Post-Treatment. Hepat Mon 2019;19. [DOI: 10.5812/hepatmon.96081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Pu X, Deng D, Chu C, Zhou T, Liu J. High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis. Sci Rep 2021;11:5081. [PMID: 33658585 DOI: 10.1038/s41598-021-84556-4] [Reference Citation Analysis]
11 Huang D, Lin T, Wang S, Cheng L, Xie L, Lu Y, Chen M, Zhu L, Shi J. The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China. BMC Infect Dis 2019;19:878. [PMID: 31640590 DOI: 10.1186/s12879-019-4459-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Ben Ayed H, Koubaa M, Yaich S, Rekik K, Ben Jemaa T, Maaloul I, Marrekchi C, Damak J, Ben Jemaa M. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Med Mal Infect 2019;49:607-15. [PMID: 30871816 DOI: 10.1016/j.medmal.2019.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Lian MJ, Zhang JQ, Chen SD, Zhang DD, Yang YY, Hong GL. Diagnostic accuracy of γ-glutamyl transpeptidase-to-platelet ratio for predicting hepatitis B-related fibrosis: a meta-analysis. Eur J Gastroenterol Hepatol 2019;31:599-606. [PMID: 30807447 DOI: 10.1097/MEG.0000000000001381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]